U.S. FDA grants tentative approval for Dr. Reddy’s twice-yearly injectable lenacapavir, advancing access to HIV prevention across 120 countries
On Nov. 2, 2026, Dr. Reddy’s Laboratories announced that the U.S. Food and Drug Administration (FDA) has granted…